We are a pioneering biotechnology company
We lead the biomedical revolution of Precision Medicine
Dr Nabil Hajji
We are working on the discovery and development of a new generation of cancer drugs.
We developed an innovative artificial intelligence system for precision oncology medicine.
KeyZell is currently working on several lines of research. On the one hand, a new first-line treatment against some types of tumors, capable of neutralizing cancer cells and preventing metastasis, based on the latest discoveries on cell apoptosis.
And on the other, an artificial intelligence system based on blockchain technology, O.P.S (Oncology Precision System), the future of precision medicine in oncology.
What do we offer?
I.A. Oncology Precision System
Cancer incidence 2020
Cancer incidence 2030
Committed to society
Get involved with KeyZell
If you want to get involved in this promising project and join us as an investor, employee, researcher, collaborator, partner, licensee... Do not hesitate to contact us.
Your reputation is our hallmark
Collaborators in prestigious Institutions
News and developments
We lead the Precision Medicine biomedical revolution
This represents a huge opportunity for both patients and the sector in terms of economics and innovation